A new, oral, small-molecule Tyrosine Kinase Inhibitor (TKI) for the treatment of CML. Antineoplastic. Form: Off-White to Light Tan Solid Melting Point: 259-262C Solubility: Dimethyl Sulfoxide, Methanol
Molecular Weight:
496.05
Form:
Off-White to Light Tan Solid
* VAT and and shipping costs not included. Errors and price changes excepted